These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 16765490

  • 1. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N, Jansson UB, Alm B.
    Vaccine; 2006 Jul 26; 24(31-32):5800-5. PubMed ID: 16765490
    [Abstract] [Full Text] [Related]

  • 2. Effect of choice of measles-mumps-rubella vaccine on immediate vaccination pain in infants.
    Ipp M, Cohen E, Goldbach M, Macarthur C.
    Arch Pediatr Adolesc Med; 2004 Apr 26; 158(4):323-6. PubMed ID: 15066870
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.
    Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835
    [Abstract] [Full Text] [Related]

  • 4. Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children.
    Wood C, von Baeyer CL, Bourrillon A, Dejos-Conant V, Clyti N, Abitbol V.
    Vaccine; 2004 Nov 25; 23(2):127-31. PubMed ID: 15531028
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986 Nov 25; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 25; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

  • 7. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Oct 25; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 8. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC, Núñez Mateos JC, Rodrigo Sánchez N, Martín Sánchez AM.
    An Esp Pediatr; 1992 Apr 25; 36(4):293-7. PubMed ID: 1605414
    [Abstract] [Full Text] [Related]

  • 9. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K, Goa KL.
    Drugs; 2003 Apr 25; 63(19):2107-26. PubMed ID: 12962524
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children.
    Kanra G, Ceyhan M, Ozmert E.
    Turk J Pediatr; 2000 Dec 01; 42(4):275-7. PubMed ID: 11196741
    [Abstract] [Full Text] [Related]

  • 17. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.
    Bone Marrow Transplant; 2004 Jun 01; 33(12):1187-90. PubMed ID: 15077129
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.